Effects of yeast probiotic formulation on viability, revival and protection against infection with Salmonella enterica ssp enterica serovar Typhimurium in mice

被引:19
作者
Martins, F. S. [1 ]
Veloso, L. C. [1 ]
Arantes, R. M. E. [2 ]
Nicoli, J. R. [1 ]
机构
[1] Univ Fed Minas Gerais, Dept Microbiol, Inst Ciencias Biol, BR-30161970 Belo Horizonte, MG, Brazil
[2] Univ Fed Minas Gerais, Dept Patol Geral, Inst Ciencias Biol, BR-30161970 Belo Horizonte, MG, Brazil
关键词
probiotic; Saccharomyces boulardii; Saccharomyces cerevisiae; Salmonella enterica serovar Typhimurium; SACCHAROMYCES-CEREVISIAE; BOULARDII; STRAINS;
D O I
10.1111/j.1472-765X.2009.02732.x
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
Aims: To compare the effects of five yeast probiotic formulations on viability, revival and washout kinetic in the digestive tract of mice, and the protection against an experimental infection with Salmonella enterica serovar Typhimurium. Methods and Results: The number of viable cells in five commercial probiotic products codified as A, B, C and D (Saccharomyces boulardii- lyophilized) and E (Saccharomyces cerevisiae- aqueous suspension) was determined, as well as revival and washout kinetic in mouse intestine. Protective capacity was evaluated by survival rate and histopathology of liver and intestine of mice treated with each product and then challenged with Salm. Typhimurium. Conclusions: Product A contained the highest number of viable cells and, fed to mice, gave the highest counts of viable yeasts and the longest persistence in faeces. Probably as a consequence, the highest survival and protection of intestinal and hepatic tissues were observed when product A was used for mouse treatment. Product E showed low counts in the formulation and was not recovered from mouse intestine. Significance and Impact of the Study: Formulation (lyophilization or aqueous suspension) is an important factor for revival and survival of a probiotic product in vivo and consequently for its protective properties.
引用
收藏
页码:738 / 744
页数:7
相关论文
共 20 条
[1]  
[Anonymous], 1996, GUID CAR US LAB AN
[2]   The indigenous gastrointestinal microflora [J].
Berg, RD .
TRENDS IN MICROBIOLOGY, 1996, 4 (11) :430-435
[3]   Yeast as probiotics - Saccharomyces boulardii [J].
Czerucka, D. ;
Piche, T. ;
Rampal, P. .
ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2007, 26 (06) :767-778
[4]   Experimental effects of Saccharomyces boulardii on diarrheal pathogens [J].
Czerucka, D ;
Rampal, P .
MICROBES AND INFECTION, 2002, 4 (07) :733-739
[5]   Enhanced pathogenicity of susceptible strains of the Bacteroides fragilis group subjected to low doses of metronidazole [J].
Diniz, CG ;
Arantes, RM ;
Cara, DC ;
Lima, FL ;
Nicoli, JR ;
Carvalho, MAR ;
Farias, LM .
MICROBES AND INFECTION, 2003, 5 (01) :19-26
[6]   Secreted bioactive factors from Bifidobacterium infantis enhance epithelial cell barrier function [J].
Ewaschuk, Julia B. ;
Diaz, Hugo ;
Meddings, Liisa ;
Diederichs, Brendan ;
Dmytrash, Andrea ;
Backer, Jody ;
Langen, Mirjam Looijer-van ;
Madsen, Karen L. .
AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY, 2008, 295 (05) :G1025-G1034
[7]  
Fietto JLR, 2004, CAN J MICROBIOL, V50, P615, DOI [10.1139/w04-050, 10.1139/W04-050]
[8]  
He F, 2005, MICROBIOL IMMUNOL, V49, P995
[9]   DNA from probiotic bacteria modulates murine and human epithelial and immune function [J].
Jijon, H ;
Backer, J ;
Diaz, H ;
Yeung, H ;
Thiel, D ;
McKaigney, C ;
De Simone, C ;
Madsen, K .
GASTROENTEROLOGY, 2004, 126 (05) :1358-1373
[10]  
Marten J, 2006, ARCHIT DIGEST, V63, P36